None listed
Conditions
Brief summary
This study aim to determine the minimum alveolar concentration of sevoflurane to maintain the bispectral index below 50 in 95% of patients undergoing major vascular surgery. This will permit to better choose sevoflurane concentration that allow an adequate anaesthesia with a minimal risk of memorisation even when bispectral index is unavailable.
Interventions
ASA physical status I and II patients scheduled to undergo major vascular surgery are enrolled in this study. Monitoring consists on blood pressure, heart rate, pulse oxymetry, endtidal CO2, entidal sevoflurane and bispectral index. Induction of anaesthesia is standardized in all patients using target controlled infusion of propofol and remifentanil. Muscle relaxation is achieved with cisatracurium. After tracheal intubation, propofol infusion is stopped. When the bispectral index reach 65 sevoflurane inhalation is started at the predetermined concentration. The predetermined endtidal concentration for the first patient is 2%. Sevoflurane is used once only to maintain anaesthesia. The endtidal sevoflurane concentration is adjusted with starting dose of 2% for the first patient and maintained for 10 min to ensure equilibration with the cerebral anesthetic partial pressure followed by assessment of BIS. In the next patients doses are given according to the following rule: if the subject responds positively (BIS<50 after 10 minutes of sevoflurane), the endtidal concentration is decreased by 0.2% step for the next subject, and conversely, if the subject does not respond (BIS>50 after 10 minutes of sevoflurane), the dose is increased by 0.2% step. The ED50 and ED95 of sevoflurane to maintain bispectral index below 50 are calculated using probit transformation.
Sponsors
Study design
Eligibility
Inclusion criteria
ASA I or II adults scheduled to undergo major vascular surgery under general anaesthesia
Exclusion criteria
Known allergy to sevoflurane Previous renal disease